Lupin to set up two new R&D centres in US

07 Jul 2014 Evaluate

In a view to focus on research in inhalation and on complex formulations, Pharma major Lupin is in the process of setting up two dedicated Centres of Excellence for research in inhalation and complex injectables in Florida and Maryland in the US.

The company had also increased research and development spending to Rs 958.28 crore in FY 14 as compared to Rs 770.85 crore in the FY 13.

The company continues to invest heavily in its Research and Development (R&D) programmes and in FY 2014, the company invested 8.6% of its net sales in R&D and related spends, amounting to Rs 958.30 crore. It had invested 8.1% of its net sales in R&D and related spends amounting to Rs 770.85 crore in FY 13.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.

Lupin Share Price

2112.95 3.95 (0.19%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×